CD14 and cardiac hypertrophy: On the contrary, Shahini et al. (30) found that CD14 deficiency does not attenuate systolic blood pressure nor structure, function, or fibrosis within the myocardium, suggesting that its inhibition does not affect the maladaptive cardiac hypertrophy induced by Ang II.